Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
Neurable, the leader in noninvasive brain-computer interface (BCI) technology, and HP Inc.'s HyperX, a leading gaming brand, ...
The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...
The BLA was resubmitted in 2025, after Atara and the FDA aligned on the criteria and addressed the initial CRL conditions.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
We’ve come up with a balance of Y2K, late-2000s, Tumblr-era, and recency-biased records to share. This updated list is an ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
Omega Laboratories, Inc. (Omega), a leading provider of comprehensive drug testing solutions, announces that its state-of-the ...
The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.
GrayMatters Health (GMH), the pioneers of digital brain-region biomarkers for mental healthcare, today announced the publication of new clinical and scientific research that significantly broadens the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback